Engineered TCR and CAR Immunotherapeutics Analysis Report

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Engineered TCR and CAR Immunotherapeutics Analysis Report 2015

Dublin, March 19, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/l3...neered_tcr ) has announced the addition of the "Engineered TCR and CAR Immunotherapeutics 2015" report to their offering.

This report Engineered TCR and CAR Immunotherapeutics 2015: A comparative analysis of the landscape of and business opportunities with TCR and CAR antibodies, T cells, NK cells, TILs, DLIs & DLIs as of March 2015 brings you up-to-date regarding key players, key technologies, TCR and CAR immunotherapeutic projects, business deals and private and public financing rounds.

The report analyzes the TCR and CAR immunotherapeutic pipelines and stakeholders in the field, especially among Big Pharma/Biotech and technology companies. The report highlights the value of TCR and CAR immunotherapeutics in terms of partnering economic conditions, private financing rounds and (initial) public offerings with the resulting market capitalization of companies.

However, progress in clinical trials and supply of clinical grade batches reveals some major limitations which need to be surmounted and the problems solved if TCR and CAR immunotherapeutics want to become commercially viable and successful products. This report describes the challenges and limitations and identifies solutions provided by new technologies which offer tremendous business opportunities.

This report has been built in a bottom-up basis by desktop search to identify and describe company, product, technology and business/financing profiles which then are evaluated and analyzed with a final outlook describing perspectives with challenges and opportunities.

What will you find in the report?

  • Profiles of TCR and CAR immunotherapeutics in development
  • Competitor analysis of CD19 CAR T cells
  • Options to improve CAR T cells regarding efficacy, safety, manufacturing and commercial value
  • Target analysis of TCR T cells in R&D
  • CAR T Cell pipeline in hematology
  • CAR T Cell pipeline in solid tumors
  • Allogeneic TCR and CAR T cells in R&D
  • Universal antibody-targeted CAR T cells and NK cells
  • Pipeline of most promising TILs, NK cells, DLIs and CTLs
  • Technologies needed for next generations of TCR and CAR immunotherapeutics
  • Profiles of biotechnology companies incl. financing and licensing/partnering
  • Profiles and scope of interest of Big Pharma/Biotech companies for TCRs & CARs
  • Stakeholder analysis (established, emerging, non-US, technology providing companies)
  • Potential of alternative adoptive immunotherapies with NK cells, TILs, CTLs and DLIs
  • Analysis of major partnering deals between Big pharma and technology companies
  • Economic terms of pharma-biotech deals
  • Opportunities for biotech-biotech deals in the TCR and CAR field
  • Potential to raise private money with TCR and CAR technologies
  • Success in initial public offerings and follow on offerings with TCRs and CARs
  • Limitations and hurdles with current TCR and CAR immunotherapeutics
  • Opportunities for novel TCR and CAR immunotherapeutics
  • Pricing of TCR and CAR immunotherapeutics
  • Aspects of manufacturing and commercialization

Who will benefit from the report?

  • Venture capital, private equity and investment managers
  • Financial analysts
  • CFO
  • Business development and licensing (BDL) specialists
  • Marketing managers
  • CEO, COO and managing directors
  • Corporate strategy, product and portfolio analysts and managers
  • Chief Technology Officer
  • Cell technology and manufacturing specialists
  • Clinical and preclinical development specialists

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Profiles of TCR & CAR Immunotherapeutics, NK Cells, TILs, DLIs and CTLs

4 Pipeline Analysis

5 Technology Companies

6 Pharmaceutical Companies

7 Stakeholder Analysis

8 Selected Technology Profiles

9 Business Perspective on TCR and CAR Immunotherapeutics

10 Outlook for TCR and CAR Immunotherapeutics

Companies Mentioned

  • Adaptimmune
  • Altor Biosciences
  • Amgen
  • Applied Immune Technologies
  • AstraZeneca
  • Autolus
  • Bellicum Pharmaceuticals
  • Bluebird bio
  • Cardio3 BioSciences
  • Celgene
  • Conkwest
  • CRISPR Therapeutics
  • CytomX
  • Editas Medicine
  • Eli Lilly
  • Eureka Therapeutics
  • GlaxoSmithKline
  • Immunocore
  • Intellia Therapeutics
  • Intrexon
  • Janssen (J&J)
  • Juno Therapeutics
  • Kite Pharma
  • Lion Biotechnologies
  • Medigene
  • Nextera
  • Novartis
  • Pfizer
  • Roche
  • Servier

For more information visit http://www.researchandmarkets.com/research/l3...neered_tcr


CONTACT: CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Pharmaceuticals

Scroll down for more posts ▼

Top 10 Most Recent News Articles

S&P Global's December 8 Talk Puts Guidance in Focus

Updated Category News Views 54

A 35-minute fireside chat can be a whole lot of nothing, or it can leave a useful breadcrumb trail for shareholders willing to listen closely. S&P Global has put December 8, 2026 on the calendar, when Chief Executive Officer Martina Cheung is scheduled to appear at Goldman Sachs' 2026 Financial Services Conference in New York. Her slot runs from 5:00 p.m. to 5:35 p.m....

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 52

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading
Nevada’s Space Academy Bid Has Assets, Not a Win Yet

Updated Category News Views 29

Desert acreage and a moon-landing backstory make for a handsome pitch, but Nevada is still standing at the starting line. The state has submitted its official response to NASA’s Request for Information for a proposed United States Space Academy, and the new promotional video is meant to show why the Silver State belongs in the conversation. Fair enough. There is real...

Continue Reading
Mars Sets $2 Billion Debt Tender With Kellanova Notes

Updated Category News Views 124

A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...

Continue Reading
TEN Holdings Raises $1.0 Million as Dilution Looms

Updated Category News Views 66

A Small Raise With a Loud Message Nothing says “we need room to breathe” quite like selling 1,492,500 new shares for $0.67 apiece. TEN Holdings closed a roughly $1.0 million gross equity offering on November 20, 2026, and investors in NASDAQ:XHLD ought to look at this for what it is: a modest cash infusion that comes with immediate dilution. The company gets capital;...

Continue Reading
Sidus Gains Argotec Order, but Investors Need the Math

Updated Category News Views 149

A Real Customer Signal, Minus the Revenue Figure An updated image is the least interesting detail in this release. Sidus Space has landed a purchase order from Argotec Group to manufacture cable assemblies for the HAWK satellite platform, with delivery expected in the first quarter of 2027. That is a legitimate operational win for NASDAQ:SIDU. It brings in a new...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 49

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 78

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 73

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
Tampa General's Food Bet Earns a 2026 Innovation Award

Updated Category News Views 41

Hospital meals have long been the punchline nobody bothered to fix, which is why Tampa General Hospital's latest recognition deserves a closer look. The not-for-profit academic health system was named the 2026 Inno Pick by the Tampa Bay Business Journal for its Food as Medicine initiative, its fifth straight year landing among the publication's Inno Award honorees. Awards...

Continue Reading

Top 5 Most Recently Viewed Articles

Ivalua Celebrates Winning Multiple Best Company Awards

Updated Category News Views 104

Ivalua Celebrates Its Recognition with Multiple Best Company Awards Ivalua, a leader in spend management solutions, is excited to share its recent achievements at the Comparably Awards. The company received accolades for Happiest Employees, Best Company Perks & Benefits, and Best Company Work-Life Balance. This recognition underscores Ivalua's commitment to creating an...

Continue Reading
Global Peace Index Reveals Increasing Conflict Trends

Updated Category News Views 371

The 2025 Global Peace Index: A Rising Tide of Conflict The recently released 2025 Global Peace Index (GPI) by the Institute for Economics & Peace (IEP) highlights a troubling trend of declining global peacefulness. The report indicates that we are witnessing a significant change in the global landscape, pointing to a stark reality where conditions leading to conflict are...

Continue Reading
Innovative Device Revolutionizes Painting Techniques and Efficiency

Updated Category News Views 227

Transformative Invention for Painters In the world of painting, efficiency and effectiveness are paramount. Inventors continually seek ways to improve the tools that workers use. One new device, the LOCK & ROLL, aims to enhance the painting experience significantly. Introduction to the LOCK & ROLL This innovative invention is designed to securely anchor paint rollers atop...

Continue Reading
Norfolk Southern's Leadership Crisis: Alan Shaw's Upcoming Exit

Updated Category News Views 130

Norfolk Southern at a Crossroads as Alan Shaw Faces Scrutiny Norfolk Southern Corporation is navigating a tense moment. Chief Executive Alan Shaw is under investigation for alleged ethical violations, including a purported relationship with a company employee. The review has raised questions about leadership, culture, and what accountability should look like at one of the...

Continue Reading
West USA Realty Partners with Zillow to Enhance Listings

Updated Category News Views 235

West USA Realty Embraces Transparency with Zillow West USA Realty, a leading name in the real estate industry, is taking a bold step by aligning with Zillow's standards for consumer access to property listings. This partnership reflects a mutual commitment to transparency and aims to enhance the experience for home buyers and sellers alike. Commitment to Consumers As the...

Continue Reading